Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 425

1.

Gut Microbiome and Inflammation: A Study of Diabetic Inflammasome-Knockout Mice.

Pahwa R, Balderas M, Jialal I, Chen X, Luna RA, Devaraj S.

J Diabetes Res. 2017;2017:6519785. doi: 10.1155/2017/6519785. Epub 2017 Dec 31.

2.

Subcutaneous adipose tissue biology in metabolic syndrome.

Jialal I, Devaraj S.

Horm Mol Biol Clin Investig. 2018 Jan 20. pii: /j/hmbci.ahead-of-print/hmbci-2017-0074/hmbci-2017-0074.xml. doi: 10.1515/hmbci-2017-0074. [Epub ahead of print] Review.

PMID:
29353263
3.

Myeloperoxidase Deficiency.

Pahwa R, Jialal II.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.
2017 Dec 17.

4.

Physiology, Cholesterol.

Huff T, Jialal II.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.
2017 Nov 14.

5.

Fructosamine.

Gounden V, Jialal II.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.
2017 Dec 3.

6.

Hypopituitarism (Panhypopituitarism).

Gounden V, Jialal II.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.
2017 Nov 16.

7.

Inflammation and atherosclerosis: fulfilling Koch's postulates.

Jialal I, Vikram NK.

Ther Adv Cardiovasc Dis. 2018 Jan;12(1):5-6. doi: 10.1177/1753944717744740. Epub 2017 Nov 30. No abstract available.

PMID:
29187060
8.

Thyroid, Hashimoto Thyroiditis.

Mincer DL, Jialal II.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.
2017 Nov 16.

9.

Hypercholesterolemia.

Ibrahim MA, Jialal II.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.
2017 Nov 16.

10.

Normal uric acid levels in nascent metabolic syndrome patients residing in northern California.

Jialal I, Pahwa R, Adams-Huet B, Siegel D.

J Diabetes Complications. 2017 Nov;31(11):1639-1640. doi: 10.1016/j.jdiacomp.2017.07.021. Epub 2017 Aug 3. No abstract available.

PMID:
28899611
11.

Nutrition therapy for diabetes: Implications for decreasing cardiovascular complications.

Jialal I, Vikram N.

J Diabetes Complications. 2017 Oct;31(10):1477-1480. doi: 10.1016/j.jdiacomp.2017.07.008. Epub 2017 Jul 26. No abstract available.

PMID:
28830659
12.

Reporting LDL-cholesterol levels in the era of intensive lipid management: a clarion call.

Jialal I, Gounden V.

Clin Chem Lab Med. 2017 Aug 28;55(10):1447-1449. doi: 10.1515/cclm-2017-0639. No abstract available.

13.

Fibroblast Growth Factor 23 Predicts Mortality and End-Stage Renal Disease in a Canadian Asian Population with Chronic Kidney Disease.

Jialal I, Camacho F, Nathoo B, Tam P, Pahwa R, Wu GG.

Nephron. 2017;137(3):190-196. doi: 10.1159/000479300. Epub 2017 Jul 26.

PMID:
28743129
14.

Excessive hypercortisolemia due to ectopic Cushing's syndrome requiring extending the reportable range for plasma cortisol for management.

Furman A, Jialal I.

Clin Chem Lab Med. 2017 Nov 27;56(1):e7-e9. doi: 10.1515/cclm-2017-0431. No abstract available.

PMID:
28672733
15.

Interpretation of protein electrophoresis.

Jialal I.

Ann Clin Biochem. 2017 Sep;54(5):622. doi: 10.1177/0004563217701505. Epub 2017 May 15. No abstract available.

PMID:
28504608
16.

Underestimation of Low Density Lipoprotein-Cholesterol With the Friedewald Equation Versus a Direct Homogenous Low Density Lipoprotein-Cholesterol Assay.

Jialal I, Inn M, Siegel D, Devaraj S.

Lab Med. 2017 Aug 1;48(3):220-224. doi: 10.1093/labmed/lmx023.

PMID:
28398496
17.

The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.

Pahwa R, Adams-Huet B, Jialal I.

J Diabetes Complications. 2017 May;31(5):810-813. doi: 10.1016/j.jdiacomp.2017.02.010. Epub 2017 Feb 27.

PMID:
28285929
18.

Increased fibrosis and angiogenesis in subcutaneous gluteal adipose tissue in nascent metabolic syndrome.

Jialal I, Adams-Huet B, Major A, Devaraj S.

Diabetes Metab. 2017 Sep;43(4):364-367. doi: 10.1016/j.diabet.2016.12.004. Epub 2017 Feb 1.

PMID:
28161370
20.

Modern Management of Familial Hypercholesterolemia.

Duell PB, Jialal I.

Metab Syndr Relat Disord. 2016 Dec;14(10):463-467. Epub 2016 Oct 31. Review.

PMID:
27797643
21.

Quantification of daratumumab in the serum protein electrophoresis.

Jialal I, Pahwa R.

Clin Chem Lab Med. 2017 Feb 1;55(2):e27-e28. doi: 10.1515/cclm-2016-0679. No abstract available.

PMID:
27718485
22.

Factors that promote macrophage homing to adipose tissue in metabolic syndrome.

Jialal I, Adams-Huet B, Devaraj S.

J Diabetes Complications. 2016 Nov - Dec;30(8):1434-1436. doi: 10.1016/j.jdiacomp.2016.07.031. Epub 2016 Jul 30.

PMID:
27557909
23.

Glucagon-Like Peptide-1 Receptor Agonists and Diabetic Cardiovascular Disease: Implications of the LEADER Study.

Swislocki AL, Jialal I.

Metab Syndr Relat Disord. 2016 Oct;14(8):375-377. Epub 2016 Aug 23. No abstract available.

PMID:
27552667
24.

Investigation into the interference of the monoclonal antibody daratumumab on the free light chain assay.

Rosenberg AS, Bainbridge S, Pahwa R, Jialal I.

Clin Biochem. 2016 Oct;49(15):1202-1204. doi: 10.1016/j.clinbiochem.2016.07.016. Epub 2016 Jul 28.

PMID:
27475249
25.

Folate Insufficiency Due to Celiac Disease in a 49-Year-Old Woman of Southeast Asian-Indian Ethnicity.

Datta Mitra A, Gupta A, Jialal I.

Lab Med. 2016 Aug;47(3):259-62. doi: 10.1093/labmed/lmw036.

26.

Hypoglycemia and the predisposition to cardiovascular disease: Is the pro-inflammatory-pro-coagulant diathesis a plausible explanation?

Jialal I, Dhindsa S.

Atherosclerosis. 2016 Aug;251:504-506. doi: 10.1016/j.atherosclerosis.2016.06.006. Epub 2016 Jun 8. No abstract available.

PMID:
27318869
27.

The skinny on metabolic syndrome in adolescents.

Devaraj S, Jialal I.

Transl Pediatr. 2016 Apr;5(2):97-9. doi: 10.21037/tp.2016.03.06. No abstract available.

28.

Diagnosis of Familial Hypercholesterolemia.

Jialal I, Barton Duell P.

Am J Clin Pathol. 2016 Apr;145(4):437-9. doi: 10.1093/ajcp/aqw001. Epub 2016 Feb 15. No abstract available.

PMID:
27114384
29.

Hyperglycemia Induces Toll-Like Receptor Activity Through Increased Oxidative Stress.

Pahwa R, Jialal I.

Metab Syndr Relat Disord. 2016 Jun;14(5):239-41. doi: 10.1089/met.2016.29006.pah. Epub 2016 Apr 22. Review.

PMID:
27105077
30.

The role of the high-mobility group box1 protein-Toll like receptor pathway in diabetic vascular disease.

Pahwa R, Jialal I.

J Diabetes Complications. 2016 Aug;30(6):1186-91. doi: 10.1016/j.jdiacomp.2016.03.005. Epub 2016 Mar 11. Review.

PMID:
27037040
31.

Cadmium and atherosclerosis: Heavy metal or singing the blues?

Santos-Gallego CG, Jialal I.

Atherosclerosis. 2016 Jun;249:230-2. doi: 10.1016/j.atherosclerosis.2016.01.041. Epub 2016 Feb 4. No abstract available.

PMID:
27012656
32.

The Paradox of Increased Trimethylamine-N-Oxide Levels Following Bariatric Surgery.

Devaraj S, Jialal I.

Metab Syndr Relat Disord. 2016 May;14(4):195-6. doi: 10.1089/met.2016.29005.dev. Epub 2016 Mar 9. No abstract available.

PMID:
26958935
33.

Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx.

Pahwa R, Nallasamy P, Jialal I.

J Diabetes Complications. 2016 May-Jun;30(4):563-72. doi: 10.1016/j.jdiacomp.2016.01.014. Epub 2016 Jan 22.

PMID:
26908090
34.

The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes.

Pahwa R, Devaraj S, Jialal I.

Int J Obes (Lond). 2016 Jun;40(6):907-11. doi: 10.1038/ijo.2016.32. Epub 2016 Feb 16.

PMID:
26880233
35.

Preliminary Report of Inflammatory Markers, Oxidative Stress, and Insulin Resistance in Adolescents of Different Ethnicities.

Butani L, Dharmar M, Devaraj S, Jialal I.

Metab Syndr Relat Disord. 2016 Apr;14(3):182-6. doi: 10.1089/met.2015.0161. Epub 2016 Jan 29.

PMID:
26824677
36.

Monocyte cell adhesion molecule receptors in nascent metabolic syndrome.

Jialal I, Adams-Huet B, Devaraj S.

Clin Biochem. 2016 Apr;49(6):505-507. doi: 10.1016/j.clinbiochem.2015.12.009. Epub 2015 Dec 23.

PMID:
26724276
37.

Diabetes Management and Cardiovascular Risk: Are SGLT-2 Inhibitors the Safest?

Swislocki AL, Jialal I.

Metab Syndr Relat Disord. 2016 Feb;14(1):3-6. doi: 10.1089/met.2015.29003.swi. Epub 2015 Dec 17. Review.

PMID:
26677930
38.

Plasma fetuin-A does not correlate with monocyte TLR4 in humans.

Jialal I, Devaraj S, Adams-Huet B.

Diabetologia. 2016 Jan;59(1):222-3. doi: 10.1007/s00125-015-3809-z. Epub 2015 Nov 19. No abstract available.

PMID:
26585510
39.

Endosomal Toll-Like Receptor Status in Patients with Metabolic Syndrome.

Devaraj S, Adams-Huet B, Jialal I.

Metab Syndr Relat Disord. 2015 Dec;13(10):477-80. doi: 10.1089/met.2015.0116. Epub 2015 Oct 27.

PMID:
26505293
40.

Selective increase in monocyte p38 mitogen-activated protein kinase activity in metabolic syndrome.

Jialal I, Adams-Huet B, Pahwa R.

Diab Vasc Dis Res. 2016 Jan;13(1):93-6. doi: 10.1177/1479164115607829. Epub 2015 Oct 8.

PMID:
26449239
41.

Cellular Signaling in Metabolic Syndrome.

Pahwa R, Jialal I.

Metab Syndr Relat Disord. 2015 Nov;13(9):371-2. doi: 10.1089/met.2015.29001.jia. Epub 2015 Oct 6. No abstract available.

PMID:
26441015
42.

The Authors' Reply.

Jialal I, Rashidi HH, Sokoll LJ.

Am J Clin Pathol. 2015 Jul;144(1):174. No abstract available.

PMID:
26263572
43.

Ezetimibe-Statin Combination to Reduce Cardiovascular Events: The Evidence Base.

Jialal I, Abate N.

Metab Syndr Relat Disord. 2015 Oct;13(8):327-8. doi: 10.1089/met.2015.29000.jia. Epub 2015 Jul 15. No abstract available.

PMID:
26177147
44.

Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome.

Jialal I, Devaraj S, Bettaieb A, Haj F, Adams-Huet B.

Atherosclerosis. 2015 Jul;241(1):130-7. doi: 10.1016/j.atherosclerosis.2015.04.814. Epub 2015 May 1.

PMID:
25978344
45.

The evolving role of toll-like receptors in diabetic vascular complications.

Jialal I, Pahwa R.

J Diabetes Complications. 2015 Jul;29(5):617-20. doi: 10.1016/j.jdiacomp.2015.04.002. Epub 2015 Apr 11. No abstract available.

PMID:
25935862
46.

The Novel Role of the Kidney in Diabetes Management: Sodium-Glucose Co-Transporter 2 Inhibitors.

Swislocki AL, Jialal I.

Metab Syndr Relat Disord. 2015 Sep;13(7):287-91. doi: 10.1089/met.2015.1504. Epub 2015 Apr 20. Review.

PMID:
25893855
47.

PCSK9 inhibitors: the next frontier in low-density lipoprotein lowering.

Jialal I, Patel SB.

Metab Syndr Relat Disord. 2015 Apr;13(3):99-101. doi: 10.1089/met.2015.1503. Epub 2015 Mar 3. Review.

PMID:
25734961
48.

Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease.

Jialal I, Devaraj S.

Clin Pharmacol Ther. 2015 Aug;98(2):121-3. doi: 10.1002/cpt.105. Epub 2015 Jun 26. Review.

PMID:
25732108
49.
50.

Clinical utility of lactate dehydrogenase: a historical perspective.

Jialal I, Sokoll LJ.

Am J Clin Pathol. 2015 Feb;143(2):158-9. doi: 10.1309/AJCTP0FC8QFYDFA. No abstract available.

PMID:
25596240

Supplemental Content

Loading ...
Support Center